ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts → My top 100 stocks… (From DTI) (Ad) Free ANIP Stock Alerts $65.36 +0.41 (+0.63%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 10Before Market OpensConfirmedActual EPS (Feb. 29) $0.78 Beat By $0.20 Consensus EPS (Feb. 29) $0.58 Get ANI Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANIP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANIP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ANI Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.72$0.72$0.72 Q2 20241$0.84$0.84$0.84 Q3 20241$1.03$1.03$1.03 Q4 20241$1.09$1.09$1.09 FY 20244$3.68$3.68 $3.68ANIP Earnings Date and InformationANI Pharmaceuticals last released its quarterly earnings results on February 29th, 2024. The specialty pharmaceutical company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.20. The business earned $131.65 million during the quarter, compared to analyst estimates of $123.02 million. ANI Pharmaceuticals has generated $0.84 earnings per share over the last year ($0.84 diluted earnings per share) and currently has a price-to-earnings ratio of 77.8. Earnings for ANI Pharmaceuticals are expected to grow by 16.62% in the coming year, from $3.55 to $4.14 per share. ANI Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Friday, May 10th, 2024. ANI Pharmaceuticals will be holding an earnings conference call on Friday, May 10th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 800-938-2239 with passcode "4555224". Read More ANI Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/10/2024Confirmed)------- 2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02 million$131.65 million11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92 million$131.83 million 8/9/2023Q2 2023$0.64$1.28+$0.64$1.83$99.87 million$116.50 million 5/8/2023Q1 2023$0.16$0.97+$0.81$1.88$82.99 million$106.79 million3/9/2023Q4 2022$0.49$0.59+$0.10$1.46$86.76 million$94.23 million11/9/2022Q3 2022$0.40$0.46+$0.06$1.47$78.71 million$83.82 million Get the Latest News and Ratings for ANIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.04)($0.05)($0.01)$0.84$71.00 million$73.86 million 5/10/2022Q1 2022($0.05)($0.27)($0.22)$0.73$65.50 million$64.48 million 3/15/2022Q4 2021$0.69$0.38($0.31)$2.48$58.25 million$60.93 million 10/31/2021Q3 2021$0.70$1.01+$0.31$2.03$50.30 million$52.06 million 8/5/2021Q2 2021$0.51$0.67+$0.16$2.15$47.80 million$48.63 million 5/6/2021Q1 2021$0.71$1.04+$0.33$1.83$48.00 million$54.52 million ANI Pharmaceuticals Earnings - Frequently Asked Questions When is ANI Pharmaceuticals's earnings date? ANI Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Friday, May 10th, 2024. Learn more on ANIP's earnings history. Did ANI Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $0.78 earnings per share (EPS) to beat the analysts' consensus estimate of $0.58 by $0.20. Learn more on analysts' earnings estimate vs. ANIP's actual earnings. How much revenue does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $486.82 million. How much profit does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of $18.78 million. ANIP has generated $0.84 earnings per share over the last four quarters. What is ANI Pharmaceuticals's price-to-earnings ratio? ANI Pharmaceuticals (NASDAQ:ANIP) has a trailing price-to-earnings ratio of 77.81 and a forward price-to-earnings ratio of 18.41. What is ANI Pharmaceuticals's EPS forecast for next year? ANI Pharmaceuticals's earnings are expected to grow from $3.55 per share to $4.14 per share in the next year, which is a 16.62% increase. More Earnings Resources from MarketBeat Related Companies: Morphic Earnings Date Gyre Therapeutics Earnings Date Ligand Pharmaceuticals Earnings Date Kura Oncology Earnings Date Zai Lab Earnings Date Arcus Biosciences Earnings Date Verona Pharma Earnings Date Day One Biopharmaceuticals Earnings Date Dynavax Technologies Earnings Date Pacira BioSciences Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ANIP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.